FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology San Antonio, TX, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based Seno Medical...

OncoCyte Presents Positive Data from its Liquid Biopsy Breast Cancer Diagnostic Test at the San Antonio Breast Cancer Symposium ALAMEDA, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, today presented...

Atossa Genetics to Present at the FSX Dallas Investor Conference SEATTLE, WA--(Marketwire - Feb 5, 2013) -   Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, CFO and General Counsel, will present...

Atossa Genetics to Present at the 15th Annual BIO CEO and Investor Conference SEATTLE, WA--(Marketwire - Jan 28, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Dr. Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and...